AUA Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow Up Guideline Summary - Guideline Central

Design and created by Guideline Central in participation with the American Urological Association.

Document Overview

Document Title: Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow Up

Authoring Society: American Urological Association

Document Publication Date: Apr 30, 2021

Page Last Reviewed/Updated: May 5, 2026

Document Type: Guideline

Country of Publication: United States

Full Text Freely Available: Yes

Full Text Guideline: www.auanet.org/guidelines/guidelines/renal-mass-and-localized-renal-cancer-evaluation-management-and-follow-up

Source Citation: Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I. J Urol. 2021 Aug;206(2):199-208. doi: 10.1097/JU.0000000000001911. Epub 2021 Jul 11. PMID: 34115547. AND
Campbell SC, Uzzo RG, Karam JA, Chang SS, Clark PE, Souter L. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II. J Urol. 2021 Aug;206(2):209-218. doi: 10.1097/JU.0000000000001912. Epub 2021 Jul 11. PMID: 34115531.

Supplemental Implementation Resources

Document Scope, Criteria, and Use Cases

Scope: Assessment and Screening, Counseling, Management

Diseases/Conditions (MeSH)

D002292 - Carcinoma, Renal Cell

D002292 - Carcinoma, Renal Cell

Keywords: Radical Nephrectomy, Renal Masses, renal cancer, thermal ablation

Inclusion Criteria: Female, Male, Adult, Older Adult

Health Care Settings: Ambulatory, Hospital

Intended Users: Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Supplemental Methodology Resources: Data Supplement Data Supplement

Number of Source Documents: 424

Literature Search Start Date: Tuesday, December 31, 1996

Literature Search End Date: Tuesday, August 31, 2021

Includes peer/external review process?: Yes

Includes public comment process?: No

Methodologist involvement?: Yes

Patient involvement?: No

Includes multi-disciplinary group?: Yes

Includes systematic review?: Yes

Grades quality of strength of evidence?: Yes

Grades quality of strength of recommendation?: Yes

Discloses funding source?: Yes

Discloses conflicts of interest?: Yes

Includes benefits/harms analysis with recommendations?: Yes